J. MEDICAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
J. MEDICAL
Largest movements
- Cash +€69,759
up €69,759 (+21.4%), from €325,981 to €395,740
mainly Net result for the year (+€86,980) and Depreciation (+€12,631)
- Tangible fixed assets -€11,782
down €11,782 (-11.1%), from €105,944 to €94,162
of which Land and buildings: -€10,719
- Receivables within one year -€9,402
no longer reported in 2025 (was €9,402)
- Reserves +€37,987
up €37,987 (+11.3%), from €337,368 to €375,355
- Other debts +€9,758
up €9,758 (+24.1%), from €40,534 to €50,292
- Gross operating margin +€9,762
up €9,762 (+6.8%), from €144,083 to €153,845
- Depreciation -€5,488
down €5,488 (-30.3%), from €18,119 to €12,631
- Taxes +€4,711
up €4,711 (+15.9%), from €29,709 to €34,421
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €450,226 | €496,862 | +€46,637 | +10.4% |
| Fixed assets | 21/28 | €105,944 | €94,162 | -€11,782 | -11.1% |
| Tangible fixed assets | 22/27 | €105,944 | €94,162 | -€11,782 | -11.1% |
| Land and buildings | 22 | €103,314 | €92,594 | -€10,719 | -10.4% |
| Plant, machinery and equipment | 23 | €1,173 | €919 | -€254 | -21.7% |
| Furniture and vehicles | 24 | €1,457 | €648 | -€808 | -55.5% |
| Current assets | 29/58 | €344,282 | €402,700 | +€58,418 | +17.0% |
| Amounts receivable within one year | 40/41 | €9,402 | - | -€9,402 | |
| Other amounts receivable | 41 | €9,402 | - | -€9,402 | |
| Cash at bank and in hand | 54/58 | €325,981 | €395,740 | +€69,759 | +21.4% |
| Deferred charges and accrued income | 490/1 | €8,899 | €6,960 | -€1,939 | -21.8% |
| Total equity and liabilities | 10/49 | €450,226 | €496,862 | +€46,637 | +10.4% |
| Equity | 10/15 | €386,474 | €424,461 | +€37,987 | +9.8% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €337,368 | €375,355 | +€37,987 | +11.3% |
| Distributable reserves | 133 | €337,368 | €375,355 | +€37,987 | +11.3% |
| Profit (loss) carried forward | 14 | €30,506 | €30,506 | = | 0.0% |
| Amounts payable | 17/49 | €63,751 | €72,401 | +€8,649 | +13.6% |
| Amounts payable within one year | 42/48 | €63,751 | €72,401 | +€8,649 | +13.6% |
| Current portion of amounts payable after more than one year | 42 | €7,359 | €3,500 | -€3,859 | -52.4% |
| Trade debts | 44 | €2,734 | €2,882 | +€147 | +5.4% |
| Suppliers | 440/4 | €2,734 | €2,882 | +€147 | +5.4% |
| Taxes, remuneration and social security | 45 | €13,124 | €15,727 | +€2,603 | +19.8% |
| Taxes | 450/3 | €7,630 | €12,008 | +€4,378 | +57.4% |
| Remuneration and social security | 454/9 | €5,494 | €3,719 | -€1,775 | -32.3% |
| Other amounts payable | 47/48 | €40,534 | €50,292 | +€9,758 | +24.1% |
| Remuneration, social security and pensions | 62 | €22,858 | €24,089 | +€1,230 | +5.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €18,119 | €12,631 | -€5,488 | -30.3% |
| Other operating charges | 640/8 | €1,614 | €999 | -€615 | -38.1% |
| Gross operating margin | 9900 | €144,083 | €153,845 | +€9,762 | +6.8% |
| Operating profit (loss) | 9901 | €101,492 | €116,126 | +€14,634 | +14.4% |
| Financial income | 75/76B | €5,111 | €5,685 | +€575 | +11.2% |
| Recurring financial income | 75 | €5,111 | €5,685 | +€575 | +11.2% |
| Financial charges | 65/66B | €591 | €411 | -€180 | -30.4% |
| Recurring financial charges | 65 | €591 | €411 | -€180 | -30.4% |
| Profit (loss) for the period before taxes | 9903 | €106,012 | €121,400 | +€15,389 | +14.5% |
| Income taxes | 67/77 | €29,709 | €34,421 | +€4,711 | +15.9% |
| Profit (loss) for the period | 9904 | €76,302 | €86,980 | +€10,677 | +14.0% |
| Profit (loss) for the period to be appropriated | 9905 | €76,302 | €86,980 | +€10,677 | +14.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 October 2026 via checked.be.